Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Telesis Bio, Inc. - Common Stock (NQ: TBIO )

0.4187 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 59
Open 0.4187
Bid (Size) 0.3702 (1)
Ask (Size) 0.4500 (1)
Prev. Close 0.4187
Today's Range 0.4187 - 0.4187
52wk Range 0.3000 - 3.320
Shares Outstanding 75,586,714
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's time to start the week with a breakdown of the biggest pre-market stock movers that are worth watching on Monday morning! 
Via InvestorPlace

Performance

YTD
-69.21%
-69.21%
1 Month
-42.72%
-42.72%
3 Month
-67.79%
-67.79%
6 Month
-79.48%
-79.48%
1 Year
-69.21%
-69.21%

More News

Read More
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Faraday Future Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Recap: Telesis Bio Q3 Earnings
Via Benzinga
Preview: Telesis Bio's Earnings
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Telesis Bio Reports Third Quarter 2023 Financial Results
From Telesis Bio
Via GlobeNewswire
Telesis Bio to Report Third Quarter Financial Results on Monday, November 13, 2023
From Telesis Bio
Via GlobeNewswire
Telesis Bio Announces Commercial Release of Cell-free Amplification Kit for Generation of Transfection-scale DNA
From Telesis Bio
Via GlobeNewswire
Earnings Scheduled For November 13, 2023
Via Benzinga
Telesis Bio Announces Commercial Release of BioXp® NGS Library Prep Kit for WGS
From Telesis Bio
Via GlobeNewswire
Telesis Bio Appoints William J. Kullback Chief Financial Officer
From Telesis Bio
Via GlobeNewswire
Pfizer Collaboration Offers Potential Milestone Windfalls For TBIO, Despite Financial Hurdles: Analyst
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 11, 2023
Via Benzinga
Telesis Bio Reports Second Quarter 2023 Financial Results
From Telesis Bio
Via GlobeNewswire
Telesis Bio to Report Second Quarter Financial Results on Thursday, August 10, 2023
From Telesis Bio
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Earnings Scheduled For August 10, 2023
Via Benzinga
Telesis Bio to Present at Jefferies Healthcare Conference 2023
From Telesis Bio
Via GlobeNewswire
Telesis Bio to Present at Antibody Engineering and Therapeutics, Europe 2023
From Telesis Bio
Via GlobeNewswire
Telesis Bio Announces Closing of $28.0 Million Private Placement of Preferred Stock And Warrants to Purchase an Additional $46.2 Million of Common Stock
From Telesis Bio
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.